Allopurinol
Allopurinol Medreg contains the active substance allopurinol. This medication belongs to a group of medications called enzyme inhibitors, which control the rate of certain chemical changes in the body.
Allopurinol Medreg is used to treat conditions where the body produces too much uric acid, such as gout, certain types of kidney disease and kidney stones, cancer, and certain enzymatic disorders that lead to excessive accumulation of uric acid.
In case of doubts before taking the medication, consult a doctor.
Before starting to take Allopurinol Medreg, discuss it with your doctor if:
Be particularly careful when taking Allopurinol Medreg:
Use in children and adolescents is rarely indicated, except for certain types of cancer (especially leukemia) and certain enzymatic disorders, such as Lesch-Nyhan syndrome.
Tell your doctor or pharmacist about all medications the patient is currently taking or has recently taken, as well as any medications the patient plans to take.
It is essential to inform the doctor if the patient is taking any of the following medications (in case of doubts, consult a doctor):
In case of concurrent administration of aluminum hydroxide, the effect of allopurinol may be reduced. There should be an interval of at least 3 hours between taking both medications.
In case of administration of allopurinol and cytostatics (e.g., cyclophosphamide, doxorubicin, bleomycin, procarbazine, alkyl halides), blood morphology disorders occur more frequently than when these active substances are administered separately. Blood morphology disorders occur when allopurinol is taken concurrently with cytostatics.
Therefore, blood morphology should be regularly monitored.
Avoid concurrent administration of 6-mercaptopurine or azathioprine with allopurinol. During concurrent administration of 6-mercaptopurine or azathioprine with Allopurinol Medreg, the dose of 6-mercaptopurine or azathioprine should be reduced, as their effect will be prolonged.
This may increase the risk of serious blood disorders. In such cases, the doctor will closely monitor the patient's blood cell count during treatment.
Seek medical attention immediately if the patient notices any unexplained bruising, bleeding, fever, or sore throat.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor or pharmacist before taking this medication.
Allopurinol passes into breast milk. It is not recommended to take allopurinol during breastfeeding.
Allopurinol Medreg may cause drowsiness or coordination problems in some people. Do not drive or operate machinery until the patient knows how the medication affects them.
If the patient has been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medication.
This medication contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".
Take this medication always exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
The dose of Allopurinol Medreg that can be taken by different people may vary greatly. The doctor will decide what dose of Allopurinol Medreg is suitable for the patient.
Usually, the initial dose is 100 to 300 mg per day and can be taken as a single dose after a meal. The tablets should be swallowed with a glass of water to facilitate swallowing.
The dose can be increased to 900 mg per day, depending on the severity of the patient's condition.
Doses greater than 300 mg should be divided into doses not exceeding 300 mg at any given time.
In the case of elderly patients or patients with liver or kidney function disorders, the doctor may prescribe a lower dose or recommend taking the medication at longer intervals. If the patient is dialyzed two or three times a week, the doctor may prescribe a dose of 300 or 400 mg, which should be taken immediately after dialysis.
The doctor usually starts treatment with a low dose of allopurinol (e.g., 100 mg/day) to reduce the risk of side effects. If necessary, the dose will be increased.
Usually, the dose is 100 to 400 mg per day.
In case of taking too many tablets or accidental ingestion by another person, seek medical attention immediately or go to the hospital. Bring the medication packaging with you. Symptoms of overdose may include nausea, vomiting, diarrhea, and dizziness.
If a dose is missed, take it as soon as possible. However, if it is almost time for the next dose, skip the missed dose. Do not take a double dose to make up for the missed dose.
Do not stop taking Allopurinol Medreg without consulting your doctor first.
In case of any further doubts about taking this medication, consult a doctor or pharmacist.
Like all medications, Allopurinol Medreg can cause side effects, although not everybody gets them.
Uncommon(may affect less than 1 in 100 people):
Rare(may affect less than 1 in 1,000 people):
Very rare(may affect less than 1 in 10,000 people):
THESE SYMPTOMS MAY INDICATE THAT THE PATIENT IS ALLERGIC TO ALLOPURINOL MEDREG. DO NOT TAKE ANY MORE TABLETS WITHOUT CONSULTING A DOCTOR FIRST.
Other side effects:
Uncommon(may affect less than 1 in 100 people):
Rare(may affect less than 1 in 1,000 people):
Very rare(may affect less than 1 in 10,000 people):
Frequency not known(cannot be estimated from the available data):
If side effects occur, including any not listed in this leaflet, inform your doctor or pharmacist. Side effects can be reported directly to the Department of Pharmacovigilance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
There are no special storage instructions for this medication.
Do not use this medication after the expiry date stated on the carton and blister after EXP.
The expiry date refers to the last day of the month.
Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medications that are no longer needed. This will help protect the environment.
White or almost white, round, biconvex, uncoated tablets with a diameter of about 11 mm, with the markings "AL" and "300" separated by a dividing line on one side and smooth on the other. The dividing line on the tablet is only to facilitate breaking the tablet, if the patient has difficulty swallowing it whole.
The tablets are provided in PVDC/PVC/Aluminum blisters, in a cardboard box.
Package sizes: 30, 50, 60, 90, 100, or 120 tablets.
Not all pack sizes may be marketed.
Medreg s.r.o.
Na Florenci 2116/15
Nové Město
110 00 Prague 1
Czech Republic
tel.: (+420) 516 770 199
Medis International a.s.
Výrobní závod Bolatice
Průmyslová 961/16
747 23 Bolatice
Czech Republic
Dr. Max Pharma s.r.o.
Na Florenci 2116/15
Nové Město
110 00 Prague 1
Czech Republic
Slovakia:
Allopurinol Medreg 300 mg
Czech Republic:
Allopurinol Medreg
Poland:
Allopurinol Medreg
Romania:
Alopurinol Gemax Pharma 300 mg tablets
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.